Use of Gadolinium in Individuals with Reduced Kidney Function. [PDF]
Kalantari K, Swaminathan S.
europepmc +1 more source
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRO. [PDF]
Rodby RA.
europepmc +1 more source
Sodium thiosulfate for treatment of nephrogenic systemic fibrosis with metastatic pulmonary calcification in a patient undergoing peritoneal dialysis: a case report. [PDF]
Yan Q +6 more
europepmc +1 more source
A bibliometric analysis of the 100 most influential papers on peritoneal dialysis. [PDF]
Yuan X, Li H, Zhou L, Huang Y.
europepmc +1 more source
Clinical Safety of Gadoxetate Disodium: Insights From 20 Years of Use and More Than 12 Million Administrations. [PDF]
Endrikat J +5 more
europepmc +1 more source
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: COMMENTARY. [PDF]
Abu-Alfa AK.
europepmc +1 more source
Safety of Gadoterate Meglumine: A Review of 35 Years of Clinical Use and More Than 170 Million Doses. [PDF]
Shahid I +5 more
europepmc +1 more source
Characteristics of Xerosis, Pruritus, and Pallor in Stage 5 Chronic Kidney Disease Patients Undergoing Hemodialysis at Dr. Hasan Sadikin General Hospital, Bandung. [PDF]
Dwiyana RF +6 more
europepmc +1 more source
Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure.
P. Evenepoel +8 more
semanticscholar +1 more source
Nephrogenic Systemic Fibrosis in Patients with Advanced Renal Dysfunction Following Gadolinium-based Contrast Agents. [PDF]
Mallepally A +7 more
europepmc +1 more source

